Windlas Biotech
₹552.9
+33.5 (6.45%)
20 April, 2024 03:40 BSE: 543329
NSE: WINDLASISIN: INE0H5O01029
Start SIP in Windlas Biotech
Start SIPWindlas Biotech Performance
Day Range
- Low 507
- High 568
52 Week Range
- Low 246
- High 591
- Open Price519
- Previous Close519
- Volume104758
Windlas Biotech Financials
Indicator | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|
Oper Rev Qtr Cr | 162 | 153 | 145 | 141 |
Operating Expenses Qtr Cr | 142 | 134 | 128 | 124 |
Operating Profit Qtr Cr | 20 | 19 | 17 | 16 |
Depreciation Qtr Cr | 3 | 3 | 3 | 4 |
Interest Qtr Cr | 0 | 0 | 0 | 0 |
Tax Qtr Cr | 5 | 4 | 4 | 4 |
Net Profit Qtr Cr | 15 | 14 | 12 | 11 |
Windlas Biotech Technicals
EMA & SMA
Current Price
₹552.9
+33.5 (6.45%)
- Bullish Moving Average
- ___
- 16
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹535.44
- 50 Day
- ₹521.37
- 100 Day
- ₹489.71
- 200 Day
- ₹436.29
- 20 Day
- ₹534.23
- 50 Day
- ₹526.81
- 100 Day
- ₹489.62
- 200 Day
- ₹423.93
Windlas Biotech Resistance and Support
PIVOT
₹542.49
Resistance | |
---|---|
First Resistance | 578.42 |
Second Resistance | 603.93 |
Third Resistance | 639.87 |
RSI | 56.58 |
MFI | 54.13 |
MACD Single Line | 4.96 |
MACD | 3.80 |
Support | |
---|---|
First Resistance | 516.97 |
Second Resistance | 481.03 |
Third Resistance | 455.52 |
Windlas Biotech Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 111,092 | 4,611,429 | 41.51 |
Week | 66,678 | 3,005,166 | 45.07 |
1 Month | 61,928 | 3,023,942 | 48.83 |
6 Month | 178,203 | 6,404,631 | 35.94 |
Windlas Biotech Result Highlights
Windlas Biotech Synopsis
NSE-Medical-Ethical Drugs
Windlas Biotech belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 513.08 Cr. and Equity Capital is Rs. 10.46 Cr. for the Year ended 31/03/2023. Windlas Biotech Ltd. is a Public Limited Listed company incorporated on 19/02/2001 and has its registered office in the State of Uttarakhand/Uttaranchal, India. Company’s Corporate Identification Number(CIN) is L74899UR2001PLC033407 and registration number is 033407.Market Cap | 1,154 |
Sales | 600 |
Shares in Float | 0.77 |
No of funds | 15 |
Yield | 0.76 |
Book Value | 2.88 |
U/D Vol ratio | 2.1 |
LTDebt / Equity | |
Alpha | 0.22 |
Beta | 0.93 |
Windlas Biotech
Owner Name | Mar-24 | Dec-23 | Sep-23 | Jun-23 |
---|---|---|---|---|
Promoters | 62.82% | 62.82% | 62.82% | 62.82% |
Mutual Funds | 10.37% | 10.4% | 10.43% | 10.51% |
Foreign Portfolio Investors | 1.18% | 1.35% | 0.8% | 0.8% |
Financial Institutions/ Banks | 0.04% | 0.04% | 0.04% | |
Individual Investors | 21.19% | 21.21% | 21.63% | 22.01% |
Others | 4.44% | 4.18% | 4.28% | 3.82% |
Windlas Biotech Management
Name | Designation |
---|---|
Mr. Vivek Dhariwal | Chairman & Ind.Director |
Mr. Hitesh Windlass | Managing Director |
Mr. Manoj Kumar Windlass | Joint Managing Director |
Mr. Pawan Kumar Sharma | Executive Director |
Mr. Ashok Kumar Windlass | Whole Time Director |
Mrs. Prachi Jain Windlass | Non Executive Director |
Mr. Srinivasan Venkataraman | Ind. Non-Executive Director |
Mr. Gaurav Gulati | Ind. Non-Executive Director |
Windlas Biotech Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Windlas Biotech Corporate Action
Date | Purpose | Remarks |
---|---|---|
2024-02-08 | Quarterly Results | |
2023-11-08 | Quarterly Results | |
2023-08-08 | Quarterly Results | |
2023-05-05 | Audited Results & Final Dividend | |
2023-02-08 | Quarterly Results |
Windlas Biotech FAQs
What is Share Price of Windlas Biotech ?
Windlas Biotech share price is ₹552 As on 20 April, 2024 | 03:26
What is the Market Cap of Windlas Biotech ?
The Market Cap of Windlas Biotech is ₹1150 Cr As on 20 April, 2024 | 03:26
What is the P/E ratio of Windlas Biotech ?
The P/E ratio of Windlas Biotech is 21.8 As on 20 April, 2024 | 03:26
What is the PB ratio of Windlas Biotech ?
The PB ratio of Windlas Biotech is 2.9 As on 20 April, 2024 | 03:26